Adcirca

Type: Product

Name: Adcirca

First reported May 08 2013 - Updated May 08 2013 - 2 reports

Gilead Sciences, Inc. (GILD): The Heart Of The Matter

Gilead Sciences, Inc. (NASDAQ: GILD ) has exploded over the last few years as a powerhouse of anti-viral medications. Its myriad treatments for HIV have brought in $2 billion in Q1 alone , and its hepatitis C drug Sofosbuvir recently showed phenomenal ... [Published InsiderMonkey.com - May 08 2013]

Entities: Letairis, Gilead Sciences Inc, Bosentan, Adcirca

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

United Therapeutics (UTHR) Posts Q1 EPS of $1.24

United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $1.24, which may not compare to the analyst estimate of $1.47. Revenue for the quarter came in at $245.1 million versus the consensus estimate of $241.14 million. United Therapeutics reaffirms 2013 ... [Published Street Insider - Apr 25 2013]

Entities: United Therapeutics Corp, Adcirca, Remodulin

First reported Apr 25 2013 - Updated Apr 25 2013 - 2 reports

United Therapeutics Corp

United Therapeutics Corporation Reports First Quarter 2013 Financial Results

• Total Revenues of $245.1 million• Earnings per Share of $1.24 per Basic Share or $1.19 per Diluted Share• Earnings Before Non-Cash Charges of $2.76 per Basic Share, or $2.65 per Diluted ShareUnited Therapeutics Corporation (NASDAQ: UTHR) today announced ... [Published Citybizlist - Apr 25 2013]

Entities: United Therapeutics Corp, Pulmonary Arterial Hypertension, Patient

Quotes

...providing a strong foundation for continued growth," said Martine Rothblatt, Ph D , United Therapeutics Chairman and Chief Executive Officer. "Our pipeline continues to grow, with two phase 3 trials, a new phase 1 trial of mesenchymal stem cells in PAH patients and advances in our strategic product portfolio."

United Therapeutics Corporation Reports First Quarter 2013 Financial Results [Published Citybizlist - Apr 25 2013]

...medication in the EU to provide a single treatment option for men with both ED and BPH," said Anthony Beardsworth, senior medical director at Lilly. "Since many men who have ED also experience the signs and symptoms of BPH, a single medication approved to treat both may be a useful therapeutic option for men and physicians."

Eli Lilly's Cialis gets European approval to treat signs and symptoms of benign prostatic hyperpl ... [Published PharmaBiz - Nov 01 2012]

...medication in the EU to provide a single treatment option for men with both ED and BPH," said Anthony Beardsworth, senior medical director at Lilly. "The CHMP positive opinion for Cialis marks an important regulatory milestone for Eli Lilly and Company and our commitment to bringing new treatment options to the millions of men who experience ED and BPH."

CHMP recommends approval of Lilly's Cialis tablets to treat sings & symptoms of BPH in EU [Published PharmaBiz - Sep 24 2012]

More Content

sort by: Date \| Relevance
Gilead Sciences, Inc. (GILD): The Heart Of The ... [Published InsiderMonkey.com - May 08 2013]
Gilead Shows Some Heart [Published Motley Fool - May 08 2013]
United Therapeutic's Second PAH Stumble Emphasi... [Published Seeking Alpha - Apr 30 2013]
United Therapeutics (UTHR) Posts Q1 EPS of $1.24 [Published Street Insider - Apr 25 2013]
United Therapeutics Corporation Reports First Q... [Published Citybizlist - Apr 25 2013]
United Therapeutics Corporation Reports First Q... [Published Street Insider - Apr 25 2013]
United Therapeutics Corporation (UTHR) - Financ... [Published TransWorldNews - Apr 22 2013]
Pulmonary Arterial Hypertension (PAH) Therapeut... [Published PipelineReview - Apr 20 2013]
United Therapeutics Corporation (UTHR) - Financ... [Published MarketResearch.com - Apr 19 2013]
UTHR to Move PAH Drug into Phase I Zacks [Published Yahoo! Finance - Apr 15 2013]
Merck to Present New Data on VICTRELIS® (bocepr... [Published Yahoo! Finance - Apr 08 2013]
Eli Lilly's Cialis gets European approval to tr... [Published PharmaBiz - Nov 01 2012]
CHMP recommends approval of Lilly's Cialis tabl... [Published PharmaBiz - Sep 24 2012]